Hoare, J. I., Osmani, B., O'Sullivan, E. A., Browne, A., Campbell, N., Metcalf, S., . . . Lockley, M. (2022). Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapy. Communications Biology, 5(1), 1. https://doi.org/10.1038/s42003-022-03041-4
Chicago Style (17th ed.) CitationHoare, Joseph I., et al. "Carvedilol Targets β-arrestins to Rewire Innate Immunity and Improve Oncolytic Adenoviral Therapy." Communications Biology 5, no. 1 (2022): 1. https://doi.org/10.1038/s42003-022-03041-4.
MLA (9th ed.) CitationHoare, Joseph I., et al. "Carvedilol Targets β-arrestins to Rewire Innate Immunity and Improve Oncolytic Adenoviral Therapy." Communications Biology, vol. 5, no. 1, 2022, p. 1, https://doi.org/10.1038/s42003-022-03041-4.